Novartis AG (NVS) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Drug Manufacturers - General Branche. Der Hauptsitz des Unternehmens ist in Basel, Switzerland. Der aktuelle CEO ist Vasant Narasimhan.
NVS hat IPO-Datum 1996-11-07, 75,883 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $296.06B.
Novartis AG is a global healthcare company headquartered in Basel, Switzerland, that researches, develops, manufactures, and markets a broad portfolio of prescription medicines and healthcare products worldwide. The company operates through two primary segments: Innovative Medicines, which focuses on specialty pharmaceuticals across therapeutic areas including oncology, immunology, neuroscience, ophthalmology, cardiovascular, and respiratory diseases, and Sandoz, a leading generics and biosimilars business that produces small molecule pharmaceuticals, active pharmaceutical ingredients, and biotechnology-based products. Novartis maintains strategic partnerships and collaborations with biotechnology companies to advance its clinical pipeline and expand treatment options for patients globally.
